Delivery Order SPE2DB25D2204-SPE2DB25FTGDE
Award Date
3/10/25
Potential Completion Date
3/11/25
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,903.43, was issued by the Medical Supply Chain agency of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.4 mg/ml naloxone vials, a critical medication used to treat opioid overdoses. The contract is a firm fixed-price delivery order with a completion date of June 27, 2024. While the original solicitation was not provided, the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Naloxone Hydrochloride, a medication used to reverse opioid overdose. The contract, valued at $16,000.98, is a Firm Fixed Price Delivery Order that runs through September 13, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This contract award is for the delivery of 0.4 mg/mL naloxone vials to the U.S. government. The award, valued at $1,429.38, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for $6,386.33 to supply the DLA with 0.4 mg/ml vials of the opioid overdose reversal medication naloxone. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency (DLA) awarded a $7,266.84 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4 mg/10 ml vials of the opioid overdose treatment drug naloxone. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 0.4 mg/mL naloxone vials, a medication used to reverse opioid overdose, with a total ceiling value of $1,603.45. The award has an ultimate completion date of January 24, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the Defense...
The U.S. Defense Logistics Agency (DLA) awarded a $2,320.69 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,664,956 units of 4 mg naloxone hydrochloride nasal spray. This order is part of a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
This federal contract award, valued at $1,537.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,321,657 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdoses. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. The specific award is for the supply of 0.4 mg/mL naloxone vials, a medication used to reverse opioid overdoses, with a ceiling value of $1,210.86 and...
The federal contract award is for the delivery of 4565927220 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical pharmaceutical product used for the treatment of opioid overdose. The $1,347.37 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) on September 24, 2024. The contract type is a Delivery Order with a Firm Fixed Price, and the ultimate completion date is September 25, 2024. The contract does not have a...